{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T03:14:59Z","timestamp":1767842099717,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"35","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003823","name":"Human Health Foundation","doi-asserted-by":"crossref","award":["SAB4861"],"award-info":[{"award-number":["SAB4861"]}],"id":[{"id":"10.13039\/501100003823","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.vaccine.2013.05.071","type":"journal-article","created":{"date-parts":[[2013,5,31]],"date-time":"2013-05-31T17:51:05Z","timestamp":1370022665000},"page":"3549-3557","source":"Crossref","is-referenced-by-count":15,"title":["Immunogenicity and safety of the vaccinia virus LC16m8\u0394 vector expressing SIV Gag under a strong or moderate promoter in a recombinant BCG prime-recombinant vaccinia virus boost protocol"],"prefix":"10.1016","volume":"31","author":[{"given":"Hirotaka","family":"Sato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Jing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mao","family":"Isshiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Kidokoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiki","family":"Takamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianfeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisatoshi","family":"Shida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.05.071_bib0005","series-title":"UNAIDS report on the global AIDS epidemic","year":"2012"},{"issue":"6","key":"10.1016\/j.vaccine.2013.05.071_bib0010","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa1105243","article-title":"Prevention of HIV-1 infection with early antiretroviral therapy","volume":"365","author":"Cohen","year":"2011","journal-title":"N Engl J Med"},{"issue":"5993","key":"10.1016\/j.vaccine.2013.05.071_bib0015","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.1187659","article-title":"Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1","volume":"329","author":"Wu","year":"2010","journal-title":"Science"},{"issue":"7424","key":"10.1016\/j.vaccine.2013.05.071_bib0020","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nature11544","article-title":"Broad and potent neutralization of HIV-1 by a gp41-specific human antibody","volume":"491","author":"Huang","year":"2012","journal-title":"Nature"},{"issue":"5950","key":"10.1016\/j.vaccine.2013.05.071_bib0025","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1126\/science.1178746","article-title":"Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target","volume":"326","author":"Walker","year":"2009","journal-title":"Science"},{"issue":"46","key":"10.1016\/j.vaccine.2013.05.071_bib0030","doi-asserted-by":"crossref","first-page":"18921","DOI":"10.1073\/pnas.1214785109","article-title":"Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo","volume":"109","author":"Moldt","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"10.1016\/j.vaccine.2013.05.071_bib0035","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1038\/nm.2934","article-title":"Lymph node T cell responses predict the efficacy of live attenuated SIV vaccines","volume":"18","author":"Fukazawa","year":"2012","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.vaccine.2013.05.071_bib0040","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nm.1935","article-title":"Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge","volume":"15","author":"Hansen","year":"2009","journal-title":"Nat Med"},{"issue":"7348","key":"10.1016\/j.vaccine.2013.05.071_bib0045","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature10003","article-title":"Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine","volume":"473","author":"Hansen","year":"2011","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.vaccine.2013.05.071_bib0050","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.4049\/jimmunol.150.7.3101","article-title":"Immunization with recombinant BCG-SIV elicits SIV-specific cytotoxic T lymphocytes in rhesus monkeys","volume":"150","author":"Yasutomi","year":"1993","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2013.05.071_bib0055","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.clim.2005.11.005","article-title":"Intradermal and oral immunization with recombinant Mycobacterium bovis BCG expressing the simian immunodeficiency virus Gag protein induces long-lasting, antigen-specific immune responses in guinea pigs","volume":"119","author":"Kawahara","year":"2006","journal-title":"Clin Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2013.05.071_bib0060","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1128\/CVI.00184-12","article-title":"A recombinant attenuated Mycobacterium tuberculosis vaccine strain is safe in immunosuppressed simian immunodeficiency virus-infected infant macaques","volume":"19","author":"Jensen","year":"2012","journal-title":"Clin Vaccine Immunol"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2013.05.071_bib0065","doi-asserted-by":"crossref","first-page":"C61","DOI":"10.1016\/j.vaccine.2012.02.040","article-title":"Immunising the HIV-infected child: a view from sub-Saharan Africa","volume":"30","author":"Mphahlele","year":"2012","journal-title":"Vaccine"},{"issue":"23","key":"10.1016\/j.vaccine.2013.05.071_bib0070","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand","volume":"361","author":"Rerks-Ngarm","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2013.05.071_bib0075","series-title":"Vaccinia viruses as vectors for vaccine antigens","first-page":"421","article-title":"Properties of attenuated mutant of vaccinia virus, LC16m8, derived from Lister strain","author":"Hashizume","year":"1985"},{"issue":"47\/48","key":"10.1016\/j.vaccine.2013.05.071_bib0080","doi-asserted-by":"crossref","first-page":"7009","DOI":"10.1016\/j.vaccine.2006.03.087","article-title":"LC16m8: an attenuated smallpox vaccine","volume":"24","author":"Kenner","year":"2006","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2013.05.071_bib0085","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1093\/infdis\/jir527","article-title":"Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-naive adults","volume":"204","author":"Kennedy","year":"2011","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2013.05.071_bib0090","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.1073\/pnas.0406671102","article-title":"Genetically stable and fully effective smallpox vaccine strain constructed from highly attenuated vaccinia LC16m8","volume":"102","author":"Kidokoro","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3\/4","key":"10.1016\/j.vaccine.2013.05.071_bib0095","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/BF01379134","article-title":"Constructions of vaccinia virus A-type inclusion body protein, tandemly repeated mutant 7.5kDa protein, and hemagglutinin gene promoters support high levels of expression","volume":"138","author":"Jin","year":"1994","journal-title":"Arch Virol"},{"issue":"10","key":"10.1016\/j.vaccine.2013.05.071_bib0100","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S1286-4579(02)01627-1","article-title":"Large-scale preparation of biologically active measles virus haemagglutinin expressed by attenuated vaccinia virus vectors","volume":"4","author":"Kidokoro","year":"2002","journal-title":"Microbes Infect"},{"issue":"Pt 1","key":"10.1016\/j.vaccine.2013.05.071_bib0105","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1099\/0022-1317-69-1-35","article-title":"Cloning and characterization of the gene encoding the major protein of the A-type inclusion body of cowpox virus","volume":"69","author":"Funahashi","year":"1988","journal-title":"J Gen Virol"},{"issue":"7","key":"10.1016\/j.vaccine.2013.05.071_bib0110","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.vaccine.2008.12.015","article-title":"Immunogenicity of newly constructed attenuated vaccinia strain LC16m8Delta that expresses SIV Gag protein","volume":"27","author":"Suzuki","year":"2009","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2013.05.071_bib0115","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1128\/JVI.49.3.857-864.1984","article-title":"General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes","volume":"49","author":"Mackett","year":"1984","journal-title":"J Virol"},{"issue":"Pt 6","key":"10.1016\/j.vaccine.2013.05.071_bib0120","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1099\/0022-1317-71-6-1293","article-title":"Biological and immunological characterization of influenza virus haemagglutinin expressed from the haemagglutinin locus of vaccinia virus","volume":"71","author":"Itamura","year":"1990","journal-title":"J Gen Virol"},{"issue":"20","key":"10.1016\/j.vaccine.2013.05.071_bib0125","doi-asserted-by":"crossref","first-page":"12871","DOI":"10.1128\/JVI.79.20.12871-12879.2005","article-title":"Priming-boosting vaccination with recombinant Mycobacterium bovis bacillus Calmette\u2013Gu\u00e9rin and a nonreplicating vaccinia virus recombinant leads to long-lasting and effective immunity","volume":"79","author":"Ami","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2013.05.071_bib0130","unstructured":"Codon Usage Database. Kazusa DNA Research Institute, Japan. http:\/\/www.kazusa.or.jp\/codon\/ [accessed 08.12.12]."},{"issue":"6","key":"10.1016\/j.vaccine.2013.05.071_bib0135","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1128\/IAI.55.6.1466-1475.1987","article-title":"Characterization, sequence determination, and immunogenicity of a 64-kilodalton protein of Mycobacterium bovis BCG expressed in escherichia coli K-12","volume":"55","author":"Thole","year":"1987","journal-title":"Infect Immun"},{"issue":"2-3","key":"10.1016\/j.vaccine.2013.05.071_bib0140","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1574-6968.1996.tb07995.x","article-title":"A stable Escherichia coli-mycobacteria shuttle vector \u2018pSO246\u2019 in Mycobacterium bovis BCG","volume":"135","author":"Matsumoto","year":"1996","journal-title":"FEMS Microbiol Lett"},{"issue":"10","key":"10.1016\/j.vaccine.2013.05.071_bib0145","doi-asserted-by":"crossref","first-page":"4998","DOI":"10.1128\/JVI.00138-10","article-title":"Phenotypic and functional profile of HIV-inhibitory CD8T cells elicited by natural infection and heterologous prime\/boost vaccination","volume":"84","author":"Freel","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2013.05.071_bib0150","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1146\/annurev.immunol.22.012703.104702","article-title":"Central memory and effector memory T cell subsets: function, generation, and maintenance","volume":"22","author":"Sallusto","year":"2004","journal-title":"Annu Rev Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2013.05.071_bib0155","doi-asserted-by":"crossref","first-page":"5645","DOI":"10.4049\/jimmunol.1101850","article-title":"Cross-talk between TCR and CCR7 signaling sets a temporal threshold for enhanced T lymphocyte migration","volume":"187","author":"Schaeuble","year":"2011","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2013.05.071_bib0160","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1002\/(SICI)1521-4141(199906)29:06<2037::AID-IMMU2037>3.0.CO;2-V","article-title":"Switch in chemokine receptor expression upon TCR stimulation reveals novel homing potential for recently activated T cells","volume":"29","author":"Sallusto","year":"1999","journal-title":"Eur J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2013.05.071_bib0165","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/jama.2009.289","article-title":"Clinical and immunological response to attenuated tissue-cultured smallpox vaccine LC16m8","volume":"301","author":"Saito","year":"2009","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.vaccine.2013.05.071_bib0170","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/infdis\/jiq162","article-title":"Smallpox vaccine safety is dependent on T cells and not B cells","volume":"203","author":"Gordon","year":"2011","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2013.05.071_bib0175","doi-asserted-by":"crossref","first-page":"4474","DOI":"10.1128\/JVI.62.12.4474-4480.1988","article-title":"Effects and virulences of recombinant vaccinia viruses derived from attenuated strains that express the human T-cell leukemia virus type I envelope gene","volume":"62","author":"Shida","year":"1988","journal-title":"J Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13006865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13006865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T02:39:57Z","timestamp":1688265597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13006865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":35,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0264410X13006865"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.05.071","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}